Jessica Walsh / MD Healthcare
Since joining H+K, I have held leadership roles in our New York and London teams, working on Pfizer HIV, including the FDA approval of maraviroc, and the European approval of Schering-Plough (now Merck’s) sugammadex, and Amgen’s Prolia. For four years, I led the OsteoLink team, working on behalf of the International Osteoporosis Foundation (IOF) and the University of Geneva to create the first social network dedicated to people who live with osteoporosis.
I have also recently served as a communications advisor to one of London’s largest public sector organizations, helping its management board deliver culture and organizational change. Currently, I serve as strategic team lead for Amgen and Intermune’s advocacy functions in Europe and also advise MSD on stakeholder engagement in global anesthesiology.
I began my advocacy career as an HIV antibody testing advocate with Columbia University’s Health Advocacy Program.
I am passionate about the potential of patient advocacy in an evolving health landscape (increasingly online and more transparent than ever before) and helping clients adapt to changing needs and deliver effective, mutually beneficial, programs.
I graduated from Wellesley College with honors in psychology and French. Fluent in French, I spent my post-graduate year teaching English at the political science university in Paris and interning at ABC News. In 2012, I co-wrote and produced my first short film, Wild Horses, which recently won best live-action short over fifteen minutes at the Palm Springs festival.